Dr. Parameswaran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 E. 23rd St.
Ste. 200
Sioux Falls, SD 57105Phone+1 605-322-3035Fax+1 605-322-3036
Education & Training
Royal Hospitals NHS TrustMRCPath -Diploma, Hematology /Transplant , 1994 - 1999- Postgraduate Institute of Medical Education and Research MD, Internal Medicine , 1990 - 1993
Madras Medical CollegeClass of 1989
Certifications & Licensure
SD State Medical License 2003 - 2025
MN State Medical License 2014 - 2023
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012
Clinical Trials
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
- The National Myelodysplastic Syndromes (MDS) Study Start of enrollment: 2016 Jun 13
- An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant
- Join now to see all
Publications & Presentations
PubMed
- 13 citationsRelated peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donorsMichael A. Pulsipher, Brent R. Logan, Deidre M. Kiefer, Pintip Chitphakdithai, Marcie L. Riches
Haematologica. 2019-04-01 - 27 citationsLeukapheresis guidance and best practices for optimal chimeric antigen receptor T-cell manufacturing.Muna Qayed, Joseph P McGuirk, G Doug Myers, Vinod Parameswaran, Edmund K Waller
Cytotherapy. 2022-09-01 - 2 citationsSafety and efficacy of fedratinib in patients with myelofibrosis previously treated with ruxolitinib: primary analysis of FREEDOM trial.Vikas Gupta, Abdulraheem Yacoub, Ruben A Mesa, Claire N Harrison, Alessandro M Vannucchi
Leukemia & Lymphoma. 2024-09-01
Abstracts/Posters
- An Algorithm to Facilitate Successful and Cost Effective Hematopoietic Progenitor Cell (HPC) Harvests Based on Peripheral Blood HPC CD34 CountsParameswaran R et al, February 2014Biology of Blood and Marrow Transplantation 20(2):S133-S134
- Autologous Transplantation as Consolidation Therapy for Primary CNS Lymphoma- A Single Center ExperienceRamakrishnan Parameswaran et al, ASTCT, 2/1/2013
- Zoledronic Acid for the Prevention of Skeletal Complications In Patients with Multiple Myeloma: Interim Analysis Results of the Z-MARK StudyZoledronic Acid for the Prevention of Skeletal Complications In Patients with Multiple Myeloma: Interim Analysis Results of the Z-MARK Study Noopur Raje, MD, Robert V..., Blood (2010) 116 (21): 2971., 11/19/2010
Lectures
- Sally Frank Memorial Award and Lectureship: SBB Training Program Research Projects: Overview and Practical ExamplesAABB Annual Meeting and CTTXPO 2013-Denver - 10/12/2013
Other
- The Bridge to Transplantation in Patients with Myelodysplastic Syndrome and Acute Myeloid LeukemiaVinod Parameswaran, Blood and Marrow Transplantation Reviews
http://www.bloodline.net/wp-content/uploads/2006/11/BMTR_16.3.pdf
Hawaii - 2006
Press Mentions
Eye on KELOLAND: When to VisitJuly 9th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
